Download Free Sample Report

Cancer markers refer to substances directly produced by tumor cells or induced by non-tumor cells through tumor cells.
This report contains market size and forecasts of Biomarker Testing for Cancer in global, including the following market information:

• Global Biomarker Testing for Cancer Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Biomarker Testing for Cancer Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Biomarker Testing for Cancer companies in 2021 (%)

The global Biomarker Testing for Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Protein Biomarkers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biomarker Testing for Cancer include F. Hoffmann-L A Roche, Thermo Fisher Scientific, Qiagen N.V., Bio-Rad L aboratories and llumina, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Biomarker Testing for Cancer manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biomarker Testing for Cancer Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biomarker Testing for Cancer Market Segment Percentages, by Type, 2021 (%)

• Protein Biomarkers
• Genetic Biomarkers
• Others

Global Biomarker Testing for Cancer Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biomarker Testing for Cancer Market Segment Percentages, by Application, 2021 (%)

• Diagnostics
• Research & Development
• Prognostics
• Risk Assessment
• Others

Global Biomarker Testing for Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biomarker Testing for Cancer Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Biomarker Testing for Cancer revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Biomarker Testing for Cancer revenues share in global market, 2021 (%)
• Key companies Biomarker Testing for Cancer sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Biomarker Testing for Cancer sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• F. Hoffmann-L A Roche
• Thermo Fisher Scientific
• Qiagen N.V.
• Bio-Rad L aboratories
• llumina